Stay updated on Naptumomab + Durvalumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Updates the ClinicalTrials.gov page revision/version indicator from v3.5.2 to v3.5.3, with no change to the underlying study record content.
    Difference
    0.1%
    Check dated 2026-04-24T05:47:19.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision v3.5.2 was added and revision v3.5.0 was removed from the history.
    Difference
    0.1%
    Check dated 2026-04-17T02:28:51.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and revision v3.4.3 was removed from the record history.
    Difference
    0.1%
    Check dated 2026-03-19T05:25:41.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision changed from v3.4.2 to v3.4.3 in the Record History. No study content or user actions are affected.
    Difference
    0.1%
    Check dated 2026-03-12T02:16:10.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    A new site revision entry 'Revision: v3.4.2' was added to the history, and the notices for government funding lapse and the previous 'Revision: v3.4.1' were removed from deletions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-11T11:30:13.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Site-wide notices about government funding and operating status were added, along with a site version update to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-04T07:39:51.000Z thumbnail image

Stay in the know with updates to Naptumomab + Durvalumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.